- Home
- NVAX vs MSGE Comparison
NVAX vs MSGE Comparison
Compare NVAX & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- MSGE
- Stock Information
- Founded
- NVAX 1987
- MSGE 2020
- Country
- NVAX United States
- MSGE United States
- Employees
- NVAX N/A
- MSGE N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- MSGE Services-Misc. Amusement & Recreation
- Sector
- NVAX Health Care
- MSGE Consumer Discretionary
- Exchange
- NVAX Nasdaq
- MSGE Nasdaq
- Market Cap
- NVAX 1.3B
- MSGE 1.9B
- IPO Year
- NVAX 1995
- MSGE N/A
- Fundamental
- Price
- NVAX $8.39
- MSGE $44.91
- Analyst Decision
- NVAX Buy
- MSGE Strong Buy
- Analyst Count
- NVAX 7
- MSGE 5
- Target Price
- NVAX $14.29
- MSGE $50.20
- AVG Volume (30 Days)
- NVAX 6.8M
- MSGE 370.1K
- Earning Date
- NVAX 11-11-2025
- MSGE 11-07-2025
- Dividend Yield
- NVAX N/A
- MSGE N/A
- EPS Growth
- NVAX N/A
- MSGE N/A
- EPS
- NVAX 2.54
- MSGE 0.77
- Revenue
- NVAX $1,078,718,000.00
- MSGE $942,734,000.00
- Revenue This Year
- NVAX $61.69
- MSGE $8.41
- Revenue Next Year
- NVAX N/A
- MSGE $4.79
- P/E Ratio
- NVAX $3.30
- MSGE $58.44
- Revenue Growth
- NVAX 9.22
- MSGE N/A
- 52 Week Low
- NVAX $5.01
- MSGE $28.29
- 52 Week High
- NVAX $15.22
- MSGE $45.53
- Technical
- Relative Strength Index (RSI)
- NVAX 56.61
- MSGE 73.09
- Support Level
- NVAX $7.83
- MSGE $43.06
- Resistance Level
- NVAX $8.31
- MSGE $40.92
- Average True Range (ATR)
- NVAX 0.38
- MSGE 1.09
- MACD
- NVAX 0.05
- MSGE 0.43
- Stochastic Oscillator
- NVAX 74.84
- MSGE 89.61
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.